130 related articles for article (PubMed ID: 34614239)
1. Teduglutide in short bowel syndrome patients: A way back to normal life?
Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
[TBL] [Abstract][Full Text] [Related]
2. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
[TBL] [Abstract][Full Text] [Related]
3. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
Gattini D; Belza C; Kraus R; Avitzur Y; Ungar WJ; Wales PW
Clin Nutr; 2023 Dec; 42(12):2363-2371. PubMed ID: 37862822
[TBL] [Abstract][Full Text] [Related]
6. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
Germán-Díaz M; Alcolea A; Cabello V; Blasco-Alonso J; Rodríguez A; Galera R; García-Romero R; Romero C; González-Sacristán R; Redecillas-Ferreiro S; Moreno-Villares JM; Ramos-Boluda E
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38664251
[TBL] [Abstract][Full Text] [Related]
7. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.
Jeppesen PB
Therap Adv Gastroenterol; 2012 May; 5(3):159-71. PubMed ID: 22570676
[TBL] [Abstract][Full Text] [Related]
8. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
J Pediatr Gastroenterol Nutr; 2024 Jun; ():. PubMed ID: 38873891
[TBL] [Abstract][Full Text] [Related]
9. Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report.
Takahashi T; Maejima T; Miyazaki D; Fukahori S; Hagiwara M
Int J Surg Case Rep; 2024 Apr; 117():109524. PubMed ID: 38493615
[TBL] [Abstract][Full Text] [Related]
10. Managing fluid balance and nutritional status in a short bowel syndrome patient awaiting intestinal transplant: a case report.
Bouloubasi Z; Karayiannis D; Papadopoulou A; Dimitrokallis N; Tsanasa A; Karveli E; Vougas V
Eur J Clin Nutr; 2024 May; 78(5):455-458. PubMed ID: 38267532
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Teduglutide on Real-Life Health Care Costs in Children with Short Bowel Syndrome.
Cucinotta U; Acunzo M; Payen E; Talbotec C; Chasport C; Alibrandi A; Lacaille F; Lambe C
J Pediatr; 2023 Dec; 272():113882. PubMed ID: 38135030
[TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for the treatment of short bowel syndrome.
Frau T; El Khatib M; De Dreuille B; Billiauws L; Nuzzo A; Joly F
Expert Opin Emerg Drugs; 2024 May; ():1-12. PubMed ID: 38761162
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: A systematic review and network meta-analysis.
Sabra HK; Remeih GS; Kereet IM; Hamad M; Ahmed YA; Jahangir K; Bakr MA; Alagelli FA; Sherif H; Elsaid M
J Gastrointest Surg; 2024 Apr; ():. PubMed ID: 38663565
[TBL] [Abstract][Full Text] [Related]
14. Cholecystitis following the initiation of glucagon-like peptide-2 analogue for short bowel syndrome: A case report.
Goto Y; Masumoto K; Jimbo T; Sasaki T; Tanaka Y; Shirane K
Nutr Clin Pract; 2024 May; ():. PubMed ID: 38796751
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effectiveness of Teduglutide Treatment in Patients with Short Bowel Syndrome in Slovakia-Multicenter Real-World Study.
Gombošová L; Suchanský M; Krivuš J; Hornová J; Havlíčeková Z; Fojtová A; Norek B; Valachová I; Šprláková J; Gazda J; Ondrušová M
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592065
[TBL] [Abstract][Full Text] [Related]
16. Short bowel syndrome in infancy: recent advances and practical management.
Cernat E; Corlett C; Iglesias N; Onyeador N; Steele J; Batra A
Frontline Gastroenterol; 2021; 12(7):614-621. PubMed ID: 34925748
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Intestinal Failure With Teduglutide in
Stenke E; Dunne C; Bryce-Smyth A; Hurley M; Pode-Shakked B; Anikster Y; Tan T; Kowalka A; Bech P; Bourke B
Ann Intern Med; 2024 May; ():. PubMed ID: 38710080
[No Abstract] [Full Text] [Related]
18. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
Bioletto F; D'Eusebio C; Merlo FD; Aimasso U; Ossola M; Pellegrini M; Ponzo V; Chiarotto A; De Francesco A; Ghigo E; Bo S
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215445
[TBL] [Abstract][Full Text] [Related]
19. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
[TBL] [Abstract][Full Text] [Related]
20. Teduglutide for the treatment of short bowel syndrome: a double-edged sword?
Oliveira SB; Kocoshis SA
Am J Clin Nutr; 2023 Jun; 117(6):1057-1058. PubMed ID: 37270286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
